2025 annual financial data
Lantern Pharma 2025 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -17,978,494 USD and net income was -17,119,438 USD.
Operating cash flow was -15,676,980 USD.
Get free Lantern Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -17,978,494 USD
- Net income
- -17,119,438 USD
- Operating cash flow
- -15,676,980 USD